Croda

Rheumatoid arthritis is a chronic autoimmune disease, with the features of recurrent chronic inflammation of synovial tissue, destruction of cartilage,...

A Croda Pharma Webinar - July 13, 2022 Patient compliance is paramount to the success of topical drug products, and appealing aesthetics...

Croda International Plc (‘Croda’ or ‘the company’), the company that uses smart science to create high performance ingredients and technologies...

The current research attempts different approaches to overcome the poor dissolution of budesonide (a poorly water-soluble drug) from pellet formulations....

Many formulation strategies have been employed to improve ocular bioavailability of topical eye drops. The aim of this study was...

Biotherapeutic development presents a myriad of challenges in relation to delivery, in particular for protein therapeutics. Protein delivery is complicated...

Topical drug delivery provides several benefits over other conventional routes by providing localizing therapeutic effects and also avoids the gastrointestinal...

This work focuses on the development and evaluation of a dual nanostructured lipid carrier (NLC)/Carbopol®-based hydrogel system as a potential...

The essential homeostatic process of dead cell clearance (efferocytosis) is used by viruses in an act of apoptotic mimicry. Among...

Efflux transporters distributed at the apical side of human intestinal epithelial cells actively transport drugs from the enterocytes to the...